General Electric Co.'s (NYSE: GE) GE Healthcare will pay approximately $580 million to acquire cancer diagnostic firm Clarient Inc. (Nasdaq: CLRT). Shares of Clarient soared $1.24 to $4.98 while GE stock eased 6 cents to $16.04.
Clarient To Be Acquired
October 22, 2010 at 14:36 PM EDT
